To ascertain the frequency of this molecular event and the resultant FGFR2 protein overexpression, Mathur et al. performed FGFR2 IHC on a series of primary and lymph node–metastatic CRC samples in a tissue microarray. This evidence concerns the gene FGFR2 and colorectal carcinoma.